...
首页> 外文期刊>Lipids in Health Disease >Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration
【24h】

Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration

机译:髓过氧化物酶 - 氧化高密度脂蛋白通过抑制平滑肌细胞迁移来损害动脉粥样硬化斑块稳定性

获取原文
           

摘要

BackgroundHigh density lipoprotein (HDL) has been proved to be a protective factor for coronary heart disease. Notably, HDL in atherosclerotic plaques can be nitrated (NO2-oxHDL) and chlorinated (Cl-oxHDL) by myeloperoxidase (MPO), likely compromising its cardiovascular protective effects. MethodHere we determined the effects of NO2-oxHDL and Cl-oxHDL on SMC migration using wound healing and transwell assays, proliferation using MTT and BrdU assays, and apoptosis using Annexin-V assay in vitro, as well as on atherosclerotic plaque stability in vivo using a coratid artery collar implantation mice model. ResultsOur results showed that native HDL promoted SMC proliferation and migration, whereas NO2-oxHDL and Cl-oxHDL inhibited SMC migration and reduced capacity of stimulating SMC proliferation as well as migration, respectively. OxHDL had no significant influence on SMC apoptosis. In addition, we found that ERK1/2-phosphorylation was significantly lower when SMCs were incubated with NO2-oxHDL and Cl-oxHDL. Furthermore, transwell experiments showed that differences between native HDL, NO2-oxHDL and Cl-oxHDL was abolished after PD98059 (MAPK kinase inhibitor) treatment. In aortic SMCs from scavenger receptor BI (SR-BI) deficient mice, differences between migration of native HDL, NO2-oxHDL and Cl-oxHDL treated SMCs vanished, indicating SR-BI’s possible role in HDL-associated SMC migration. Importantly, NO2-oxHDL and Cl-oxHDL induced neointima formation and reduced SMC positive staining cells in atherosclerotic plaque, resulting in elevated vulnerable index of atherosclerotic plaque. ConclusionThese findings implicate MPO-catalyzed oxidization of HDL may contribute to atherosclerotic plaque instability by inhibiting SMC proliferation and migration through MAPK-ERK pathway which was dependent on SR-BI.
机译:背景高密度脂蛋白(HDL)被证明是冠心病的保护因素。值得注意的是,通过髓氧化酶(MPO),动脉粥样硬化斑块中的HDL可以是硝化(NO 2次> -OXHDL)和氯化(CL- OXHDL),可能会影响其心血管保护作用。方法,我们确定使用伤口愈合和转发测定,使用MTT和Brdu测定的增殖,使用膜蛋白-V测定的细胞凋亡以及体外凋亡的影响与使用鳞型胶带植入小鼠模型的体内动脉粥样硬化斑稳定性。结果评估结果表明,天然HDL促进了SMC增殖和迁移,而NO 2 /亚> -OXHDL和CL- OXHDL分别抑制了SMC迁移和降低了刺激SMC增殖以及迁移的能力。 OXHDL对SMC凋亡没有显着影响。此外,当与NO 2 /亚oxOxHDL和CL- OXHDL一起温育SMC时,我们发现ERK1 / 2-磷酸化显着降低。此外,Transwell实验表明,在PD98059(MAPK激酶抑制剂)处理之后,天然HDL,NO 2 /亚> -OxHDL和CL- OXHDL之间的差异。在清除剂受体BI(SR-BI)缺乏小鼠的主动脉SMC中,天然HDL迁移之间的差异,NO 2 -OxHDL和CL-OXHDL处理的SMC消失,表明SR-BI在HDL中的可能作用相关的SMC迁移。重要的是,NO 2 -OxHDL和CL- OXHDL诱导动脉粥样硬化斑块中的内部形成和减少的SMC阳性染色细胞,导致动脉粥样硬化斑块的脆弱指数升高。结案该发现屏蔽MPO催化的HDL氧化可能通过抑制SMC增殖和通过依赖于SR-BI的迁移而导致动脉粥样硬化斑块不稳定性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号